Despite a growing number of people becoming insured in 2014, attitudes have not shifted about the Affordable Care Act.
Despite a growing number of people becoming insured in 2014, attitudes have not shifted about the Affordable Care Act.
Recent findings from a Kaiser Family Foundation poll indicate that nearly half (46%) of respondents say they viewed the health reform law unfavorably, with only 38% reporting a favorable impression of the policy.
“Despite the announcement that at least 8 million people have signed up for health insurance through the ACA’s new marketplace, overall favorability of the law remains exactly where it was in last month’s tracking poll,” said the report. “This is a slight improvement over polls taken from November through January, but still represents a more negative tilt to opinion than was measured in Kaiser tracking surveys before the troubled launch of the exchanges last October.”
Still more than half, or 58%, of poll respondents say they would support Congress if they improved the law, versus 35% who said they want it repealed completely. As well, even though enrollment numbers have reached 8 million, 57% felt the enrollment numbers were lower than anticipated. The Kaiser report also highlighted why some remain hesitant to become enrolled.
“When asked to say in their own words why they don’t currently have health insurance, the most common reason mentioned by the uninsured is that it is too expensive (39%), followed by employment-related reasons such as being unemployed or working for an employer that doesn’t offer coverage (22%),” stated the report. “Roughly 1 in 10 say they just haven’t gotten around to getting coverage or missed the deadline to apply (115), and a similar share feel they don’t want or need coverage (9%).”
Around the Web
Obamacare Remains Unpopular Despite Enrollment Surge [Modern Healthcare]
Kaiser Health Tracking Poll: April 2014 [KFF]
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
Solving the Transition Conundrum as More Children With Muscular Dystrophy Live to Adulthood
March 17th 2025Learning from examples like congenital heart disease and cystic fibrosis can help health systems and clinicians prepare to care for an influx of patients with neuromuscular diseases as they reach adulthood thanks to transformative therapy advances.
Read More